Apg-3288
Relapsed/Refractory Mantle Cell Lymphoma (MCL)
Ascentage Pharma Group Inc.Phase 1
—
Rating in progress
Apg-3288 in Relapsed/Refractory Mantle Cell Lymphoma (MCL) is in the Floatz rating universe. The engine has not yet published a v0.2 rating for this asset. This page will update automatically once scoring completes.
Methodology v0.2 · Active